Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine

Neuropsychopharmacology

Volumn 33, Issue 12, 2008, Pages 2969-2980

  Briand, Lisa A ^a   Flagel, Shelly B ^b   Garcia Fuster, M Julia ^b   Watson, Stanley J ^a,b   Akil, Huda ^a,b   Sarter, Martin ^a,c   Robinson, Terry E ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Addiction; Attention; Dopamine receptor; Medial prefrontal cortex; Orbital frontal cortex; Self administration

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TASK PERFORMANCE;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; NEURAL PATHWAYS; NEURONS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SELF ADMINISTRATION; SYNAPTIC TRANSMISSION;

EID: 47249114103     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.18     Document Type: Article

References (55)

1. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
2. Beveridge TJ, Smith HR, Daunais JB, Nader MA, Porrino LJ (2006). Chronic cocaine self-administration is associated with altered functional activity in the temporal lobes of non human primates. Eur J Neurosci 23: 3109-3118.
3. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C et al (2004). Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 16: 456-464.
4. Bolla KI, Cadet JL, London ED (1998). The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci 10: 280-289.
5. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C et al (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19: 1085-1094.
6. Bolla KI, Rothman R, Cadet JL (1999). Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 11: 361-369.
7. Burke KA, Franz TM, Gugsa N, Schoenbaum G (2006). Prior cocaine exposure disrupts extinction of fear conditioning. Learn Mem 13: 416-421.
8. Caine SB, Lintz R, Koob GF (1993). Intravenous drug self-administration techniques in animals. In: Sahgal A (ed). Publisher: Behavioral Neuroscience, a Practical Approach. Oxford University Press: New York. pp 117-143.
9. Calu DJ, Stalnaker TA, Franz TM, Singh T, Shaham Y, Schoenbaum G (2007). Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. Learn Mem 14: 325-328.
10. Crider A, Solomon PR, McMahon MA (1982). Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder. Biol Psychiatry 17: 351-361.
11. Dalley JW, Laane K, Pena Y, Theobald DE, Everitt BJ, Robbins TW (2005a). Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology (Berl) 182: 579-587.
12. Dalley JW, Theobald DE, Berry D, Milstein JA, Laane K, Everitt BJ et al (2005b). Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30: 525-537.
13. Deroche-Gamonet V, Belin D, Piazza PV (2004). Evidence for addiction-like behavior in the rat [see comment]. Science 305: 1014-1017.
14. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V et al (2002). Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology 26: 682-691.
15. Ferrario CR, Gorny G, Crombag HS, Li Y, Kolb B, Robinson TE (2005). Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58: 751-759.
16. Frey PW, Colliver JA (1973). Senstivity and responsivitiy measusres for discrimination learning. Learn Motiv 4: 327-342.
17. Garcia-Fuster MJ, Ferrer-Alcon M, Martin M, Kieffer BL, Maldonado R, Garcia-Sevilla JA (2007). Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD. Eur Neuropsychopharmacol 17: 366-374.
18. Glickstein SB, Desteno DA, Hof PR, Schmauss C (2005). Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 15: 1016-1024.
19. Goldman-Rakic PS (1995). Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci 769: 71-83.
20. Goldstein RZ, Tomasi D, Alia-Klein N, Zhang L, Telang F, Volkow ND (2007). The effect of practice on a sustained attention task in cocaine abusers. Neuroimage 35: 194-206.
21. Hoff AL, Riordan H, Morris L, Cestaro V, Wieneke M, Alpert R et al (1996). Effects of crack cocaine on neurocognitive function. Psychiatry Res 60: 167-176.
22. Imam SZ, Duhart HM, Skinner JT, Ali SF (2005). Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann N Y Acad Sci 1053: 482-490.
23. Jentsch JD, Olausson P, De La Garza II R, Taylor JR (2002). Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 26: 183-190.
24. Kabbaj M, Devine DP, Savage VR, Akil H (2000). Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 20: 6983-6988.
25. Kantak KM, Udo T, Ugalde F, Luzzo C, Di Pietro N, Eichenbaum HB (2005). Influence of cocaine self-administration on learning related to prefrontal cortex or hippocampus functioning in rats. Psychopharmacology (Berl) 181: 227-236.
26. Kondrad RL, Burk JA (2004). Transient disruption of attentional performance following escalating amphetamine administration in rats. Psychopharmacology (Berl) 175: 436-442.
27. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R et al (2006). Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31: 644-650.
28. Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M (2007). Toward a neurocognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 32: 2074-2086.
29. Liu X, Matochik JA, Cadet JL, London ED (1998). Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology 18: 243-252.
30. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ (1990). Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10: 2587-2600.
31. Mansour A, Meador-Woodruff JH, Zhou QY, Civelli O, Akil H, Watson SJ (1991). A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 45: 359-371.
32. Martinez V, Parikh V, Sarter M (2005). Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiatry 57: 1138-1146.
33. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI (2003). Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 19: 1095-1102.
34. McGaughy J, Sarter M (1995). Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117: 340-357.
35. Miller L (1985). Neuropsychological assessment of substance abusers: review and recommendations. J Subst Abuse Treat 2: 5-17.
36. Nogueira L, Kalivas PW, Lavin A (2006). Long-term neuroadaptations produced by withdrawal from repeated cocaine treatment: role of dopaminergic receptors in modulating cortical excitability. J Neurosci 26: 12308-12313.
37. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ et al (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23: 113-126.
38. Paterson NE, Markou A (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14: 2229-2232.
39. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
40. Posner MI, Rothbart MK (2007). Research on attention networks as a model for the integration of psychological science. Annu Rev Psychol 58: 1-23.
41. Rinaldi A, Mandillo S, Oliverio A, Mele A (2007). D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. Neuropsychopharmacology 32: 309-319.
42. Robbins TW (1996). Dissociating executive functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351: 1463-1470; discussion 1470-1461.
43. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K et al (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-339.
44. Rosselli M, Ardila A (1996). Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 18: 122-135.
45. Sarter M, Lustig C (2007). Attentional functions in learning and memory. In: Squire LR, Albright T, Bloom FE, Gage FH, Spitzer N (eds). New Encyclopedia of Neuroscience. Elsevier: Oxford.
46. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B (2004). Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci 19: 1997-2002.
47. Sun W, Rebec GV (2005). The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology (Berl) 177: 315-323.
48. Sun W, Rebec GV (2006). Repeated cocaine self-administration alters processing of cocaine-related information in rat prefrontal cortex. J Neurosci 26: 8004-8008.
49. Tost H, Meyer-Lindenberg A, Klein S, Schmitt A, Hohn F, Tenckhoff A et al (2006). D2 antidopaminergic modulation of frontal lobe function in healthy human subjects. Biol Psychiatry 60: 1196-1205.
50. Vanderschuren LJ, Everitt BJ (2004). Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305: 1017-1019.
51. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B et al (1991). Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 148: 621-626.
52. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988). Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry 152: 641-648.
53. Von Huben SN, Davis SA, Lay CC, Katner SN, Crean RD, Taffe MA (2006). Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys. Psychopharmacology (Berl) 188: 586-596.
54. Wang M, Vijayraghavan S, Goldman-Rakic PS (2004). Selective D2 receptor actions on the functional circuitry of working memory. Science 303: 853-856.
55. Yu AJ, Dayan P (2005). Uncertainty, neuromodulation, and attention. Neuron 46: 681-692.